Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T21:30:29.270Z Has data issue: false hasContentIssue false

08-03 From biological marker to endophenotype: the role of animal models

Published online by Cambridge University Press:  24 June 2014

D Eyles
Affiliation:
School of Biomedical Sciences, University of Queensland Queensland Centre for Mental Health Research, The Park, Wacol, Queensland, Australia
T Burne
Affiliation:
Queensland Centre for Mental Health Research, The Park, Wacol, Queensland, Australia
J McGrath
Affiliation:
Queensland Centre for Mental Health Research, The Park, Wacol, Queensland, Australia Department of Psychiatry, University of Queensland, Brisbane, Australia
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstracts from ‘Brainwaves’— The Australasian Society for Psychiatric Research Annual Meeting 2006, 6–8 December, Sydney, Australia
Copyright
Copyright © 2006 Blackwell Munksgaard

Our group has been exploring the concept that developmental vitamin D (DVD) deficiency may be the plausible neurobiological explanation for several important epidemiological correlates of schizophrenia, namely 1) the excess winter/spring birth rate, 2) increased incidence of the disease in second-generation Afro-Caribbean migrants and 3) increased urban birth rate. We have produced two pieces of direct support for this hypothesis in patients. DVD deficiency therefore is a plausible ‘biological marker’ for schizophrenia. We have recently resolved a major technological barrier that will now allow us to test this hypothesis in a major European developmental biobank. The genetic factors or heritability indicators that would endow DVD deficiency as a valid schizophrenia endopheno-type are emerging. Our group has established a highly informative animal model to study the effects of DVD deficiency on brain development. This animal model reproduces the gross pathological features of the disease, that is, ventriculomegaly as well as sensitivity to amphetamine- and MK-801-induced hyperlocomotion and impairments in latent inhibition, behaviours analogous to the positive and negative symptoms of the disease in patients. We are now examining whether this model internally fulfils certain molecular endophenotypic criteria. Our initial data are encouraging as we find a 36 ± 11% decrease in the developmental expression of the candidate endophenotypic gene for schizophrenia, COMT. This animal model continues to provide good face and some construct validity with the disease in patients and illustrates how animal models can be used to progress plausible biological markers for schizophrenia into endophenotypes.